— Know what they know.
Not Investment Advice

AMRN NASDAQ

Amarin Corporation plc
1W: -6.4% 1M: -9.8% 3M: -21.5% YTD: -10.0% 1Y: -25.8% 3Y: -32.6% 5Y: -88.6%
$12.35
-0.37 (-2.91%)
 
Weekly Expected Move ±3.9%
$11 $12 $12 $13 $13
NASDAQ · Healthcare · Drug Manufacturers - General · Tech Score Strong Sell · Power 28 · $255.4M mcap · 21M float · 0.359% daily turnover · Short 38% of daily vol

📊 Key Metrics

TTM
$186M
Revenue
-15.1% YoY
$-27M
Net Income
+73.8% YoY
$49M
Free Cash Flow
+526.4% YoY
35.5%
Gross Margin
-28.4%
Op. Margin
-18.1%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-6.0%
ROA-4.2%
ROIC-19.6%

Valuation

P/E-8.6
P/B0.6
EV/EBITDA-1.1

Leverage

Debt/Equity0.01
Current Ratio3.67
Interest Cov.0.0x

Quality Scores

Piotroski F6/9
Altman Z-1.75
Beneish M-2.91

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms